Goldman Sachs Group Inc Moderna, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,377,848 shares of MRNA stock, worth $136 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,377,848
Previous 4,185,558 19.3%
Holding current value
$136 Million
Previous $497 Million 54.58%
% of portfolio
0.04%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$63.64 - $125.14 $51.4 Million - $101 Million
-807,710 Reduced 19.3%
3,377,848 $226 Million
Q2 2024

Aug 13, 2024
BUY
$101.21 - $166.61 $25.9 Million - $42.6 Million
255,646 Added 6.51%
4,185,558 $497 Million
Q1 2024

May 15, 2024
SELL
$85.37 - $115.44 $53.1 Million - $71.8 Million
-621,714 Reduced 13.66%
3,929,912 $419 Million
Q4 2023

Feb 13, 2024
BUY
$69.51 - $104.43 $31.1 Million - $46.7 Million
447,639 Added 10.91%
4,551,626 $453 Million
Q3 2023

May 14, 2024
SELL
$96.41 - $126.61 $43.2 Million - $56.7 Million
-447,639 Reduced 9.83%
4,103,987 $424 Million
Q3 2023

Nov 14, 2023
BUY
$96.41 - $126.61 $61 Million - $80.1 Million
632,350 Added 18.21%
4,103,987 $424 Million
Q2 2023

May 14, 2024
BUY
$118.5 - $160.53 $48.9 Million - $66.2 Million
412,412 Added 13.48%
3,471,637 $422 Million
Q2 2023

Aug 14, 2023
BUY
$118.5 - $160.53 $48.9 Million - $66.2 Million
412,412 Added 13.48%
3,471,637 $422 Million
Q1 2023

May 14, 2024
BUY
$135.66 - $197.02 $41.5 Million - $60.3 Million
306,053 Added 11.12%
3,059,225 $470 Million
Q1 2023

May 11, 2023
BUY
$135.66 - $197.02 $41.5 Million - $60.3 Million
306,053 Added 11.12%
3,059,225 $470 Million
Q4 2022

May 14, 2024
BUY
$118.38 - $210.04 $176 Million - $313 Million
1,490,684 Added 118.08%
2,753,172 $495 Million
Q4 2022

Feb 13, 2023
BUY
$118.38 - $210.04 $176 Million - $313 Million
1,490,684 Added 118.08%
2,753,172 $495 Million
Q3 2022

May 14, 2024
SELL
$118.07 - $194.18 $178 Million - $293 Million
-1,506,938 Reduced 54.41%
1,262,488 $149 Million
Q3 2022

Nov 10, 2022
SELL
$118.07 - $194.18 $178 Million - $293 Million
-1,506,938 Reduced 54.41%
1,262,488 $149 Million
Q2 2022

May 14, 2024
SELL
$117.13 - $176.59 $209 Million - $315 Million
-1,782,200 Reduced 39.16%
2,769,426 $396 Million
Q2 2022

Aug 15, 2022
BUY
$117.13 - $176.59 $136 Million - $204 Million
1,156,961 Added 71.75%
2,769,426 $396 Million
Q1 2022

May 16, 2022
BUY
$126.46 - $235.05 $39.7 Million - $73.8 Million
313,877 Added 24.17%
1,612,465 $278 Million
Q4 2021

Feb 14, 2022
SELL
$225.82 - $368.51 $64.6 Million - $105 Million
-286,235 Reduced 18.06%
1,298,588 $330 Million
Q3 2021

Nov 10, 2021
BUY
$221.9 - $484.47 $352 Million - $768 Million
1,584,823 New
1,584,823 $610 Million

Others Institutions Holding MRNA

# of Institutions
953
Shares Held
240M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email